Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023
   PCE(x) -970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is -970.75 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹109.1 Cr -1.5% -3.9% -7.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,452.7 Cr 3.1% 20.9% 56.5% Stock Analytics
KIRI INDUSTRIES ₹3,188.4 Cr 5.3% 3.9% 81.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,841.7 Cr -7.6% -12.5% -15.4% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,152.8 Cr -7.1% 3.1% 46% Stock Analytics
BODAL CHEMICALS ₹860.6 Cr -4.5% -13.2% -11% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-1.5%

-3.9%

-7.9%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses